Endovascular stroke therapy: A single-center retrospective review

Neurosurgical Focus

Volumn 30, Issue 6, 2011, Pages

  Day, Jason S ^a   Hurley, Michael C ^b   Chmayssani, Mohamad ^c   Rahme, Rudy J ^b   Alberts, Mark J ^c   Bernstein, Richard A ^b   Dabus, Guilherme ^d   Shaibani, Ali ^b   Bendok, Bernard R ^b  

^a St Joseph Neurology Associates   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d BAPTIST CARDIAC AND VASCULAR INSTITUTE   (United States)

Author keywords

Endovascular; Ischemic; Mechanical; Pharmacological; Stenting; Stroke

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

AGED; ANGIOPLASTY; ARTICLE; BRAIN ISCHEMIA; CASE REPORT; CEREBRAL REVASCULARIZATION; COMPARATIVE STUDY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; MALE; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; STENT; STROKE;

AGED; ANGIOPLASTY; BRAIN ISCHEMIA; CEREBRAL REVASCULARIZATION; FEMALE; HUMANS; MALE; RETROSPECTIVE STUDIES; STENTS; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 79958791318     PISSN: None     EISSN: 10920684     Source Type: Journal    
DOI: 10.3171/2011.3.FOCUS10267     Document Type: Article

References (29)

1. Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al: Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 38:1655-1711, 2007 (Erratum in Stroke 38:e38, e96, 2007)
2. Albers GW, Olivot JM: Intravenous alteplase for ischaemic stroke. Lancet 369:249-250, 2007
3. Albers GW, Thijs VN, Wechsler L, Kemp S, Schlaug G, Skalabrin E, et al: Magnetic resonance imaging profiles predict clinical response to early reperfusion: the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) study. Ann Neurol 60:508-517, 2006
4. Berger C, Fiorelli M, Steiner T, Schäbitz WR, Bozzao L, Bluhmki E, et al: Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic? Stroke 32:1330- 1335, 2001
5. Bose A, Henkes H, Alfke K, Reith W, Mayer TE, Berlis A, et al: The Penumbra System: a mechanical device for the treatment of acute stroke due to thromboembolism. AJNR Am J Neuroradiol 29:1409-1413, 2008
6. Brandt T, von Kummer R, Müller-Küppers M, Hacke W: Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome. Stroke 27:875-881, 1996
7. Clark W, Lutsep H, Barnwell S, Nesbit G, Egan R, North E, et al: Penumbra pivotal stroke trial investigators: the penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 40:2761-2768, 2009
8. Del Zoppo GJ, Saver JL, Jauch EC, Adams HP Jr, American Heart Association Stroke Council: Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke 40:2945-2848, 2009 (Erratum in Stroke 41:e562, 2010)
9. Eckert B, Koch C, Thomalla G, Kucinski T, Grzyska U, Roether J, et al: Aggressive therapy with intravenous abciximab and intra-arterial rtPA and additional PTA/stenting improves clinical outcome in acute vertebrobasilar occlusion: combined local fibrinolysis and intravenous abciximab in acute vertebrobasilar stroke treatment (FAST): results of a multicenter study. Stroke 36:1160-1165, 2005
10. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, et al: Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 282:2003- 2011, 1999
11. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, et al: Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 363:768-774, 2004
12. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, et al: Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359:1317-1329, 2008
13. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al: Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 352:1245-1251, 1998
14. IMS Study Investigators: Combined intravenous and intraarterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 35:904-911, 2004
15. IMS II Trial Investigators: The Interventional Management of Stroke (IMS) II Study. Stroke 38:2127-2135, 2007
16. Jansen O, von Kummer R, Forsting M, Hacke W, Sartor K: Thrombolytic therapy in acute occlusion of the intracranial internal carotid artery bifurcation. AJNR Am J Neuroradiol 16:1977-1986, 1995
17. Kakuda W, Lansberg MG, Thijs VN, Kemp SM, Bammer R, Wechsler LR, et al: Optimal definition for PWI/DWI mismatch in acute ischemic stroke patients. J Cereb Blood Flow Metab 28:887-891, 2008
18. Lansberg MG, Albers GW, Wijman CAC: Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors. Cerebrovasc Dis 24:1-10, 2007
19. Lee KY, Han SW, Kim SH, Nam HS, Ahn SW, Kim DJ, et al: Early recanalization after intravenous administration of recombinant tissue plasminogen activator as assessed by preand post-thrombolytic angiography in acute ischemic stroke patients. Stroke 38:192-193, 2007
20. Lutsep HL, Rymer MM, Nesbit GM: Vertebrobasilar revascularization rates and outcomes in the MERCI and multi-MERCI trials. J Stroke Cerebrovasc Dis 17:55-57, 2008
21. Meyers PM, Schumacher HC, Higashida RT, Barnwell SL, Creager MA, Gupta R, et al: Indications for the performance of intracranial endovascular neurointerventional procedures: a scientific statement from the American Heart Association Council on Cardiovascular Radiology and Intervention, Stroke Council, Council on Cardiovascular Surgery and Anesthesia, Interdisciplinary Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research. Circulation 119:2235-2249, 2009
22. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581-1587, 1995
23. Nogueira RG, Schwamm LH, Hirsch JA: Endovascular approaches to acute stroke, part 1: drugs, devices, and data. AJNR Am J Neuroradiol 30:649-661, 2009
24. Nogueira RG, Yoo AJ, Buonanno FS, Hirsch JA: Endovascular approaches to acute stroke, part 2: a comprehensive review of studies and trials. AJNR Am J Neuroradiol 30:859-875, 2009
25. Ogawa A, Mori E, Minematsu K, Taki W, Takahashi A, Nemoto S, et al: Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the Middle Cerebral Artery Embolism Local Fibrinolytic Intervention Trial (MELT) Japan. Stroke 38:2633-2639, 2007
26. Smith WS, Sung G, Saver J, Budzik R, Duckwiler G, Liebeskind DS, et al: Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 39:1205-1212, 2008
27. Smith WS, Sung G, Starkman S, Saver JL, Kidwell CS, Gobin YP, et al: Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 36:1432-1438, 2005
28. Williams LS, Yilmaz EY, Lopez-Yunez AM: Retrospective assessment of initial stroke severity with the NIH Stroke Scale. Stroke 31:858-862, 2000
29. Wilson JT, Hareendran A, Grant M, Baird T, Schulz UG, Muir KW, et al: Improving the assessment of outcomes in stroke: use of a structured interview to assign grades on the modified Rankin Scale. Stroke 33:2243-2246, 2002